NCT06118749View on ClinicalTrials.gov

Leishmania Antigen Rapid Diagnostic Test Proof-of-Concept and Validation Study

TerminatedOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

December 20, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Visceral Leishmaniasis
Interventions
DIAGNOSTIC_TEST

Antigen detection Rapid Diagnostic Test prototype

The study will focus on the usability and diagnostic performance of the RDT in blood and/or urine from patients with visceral leishmaniasis.

Trial Locations (1)

Unknown

KEMRI, Nairobi

Sponsors
All Listed Sponsors
collaborator

Kenya Medical Research Institute

OTHER

lead

Foundation for Innovative New Diagnostics, Switzerland

OTHER